Comparison of immunohistochemical and biochemical measurement of steroid receptors in breast cancer: Are both still necessary?

Breast

Volumn 10, Issue 6, 2001, Pages 470-475

  Gotlieb, L ^a   Kaufman, L ^b   Leclercq, G ^c   Nogaret, J M ^c   Buggenhout, A ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MEDICAL DECISION MAKING; MEDICAL RESEARCH; PATIENT CODING; PRIORITY JOURNAL; PROBABILITY; REFERENCE VALUE; TISSUE SECTION;

EID: 0035216598     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.2000.0283     Document Type: Article

References (28)

1. Revision of the standards for the assessment of hormone receptors in human breast cancer: Report of the second EORTC Workshop held March 16-17 in The Netherlands Cancer institute
2. Estrogen receptor concentration in low protein breast cancer cytosols
3. Estrogen and progesterone receptor status by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyser in 236 early-stage breast carcinoma: Prognostic significance
4. The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis
5. Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
6. Cancer of the breast and the receptor status
7. Long term prognostic role of steroid receptors in cancer of the breast
8. Clinical significance of steroid receptors in breast cancer
9. Immunohistochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: Comparison with quantitative biochemical methods
10. Prognostic significance of estrogen receptors in 405 primary breast cancers: A comparison of immunohistochemical and biochemical methods
11. Clinical usefulness of estrogen receptor immonocytochemistry in human breast cancer
12. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assays for predicting response to adjuvant therapy in breast cancer
13. Estrogen receptor (ER) and progesterone receptor (PgR) by ligand-binding assay compared with ER, PgR and pS2 by immunohistochemistry in predicting response to tamoxifen in metastatic breast cancer. A Southwest Oncology Group Study
14. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information
15. Correlations between progesterone receptor and patients characteristics in human breast cancer
16. The prognostic role of progesterone receptor in human breast cancer
17. On behalf of the EORTC Receptor Study Group. Steroid receptor distribution in 47 892 breast cancers. A collaborative study of 7 European laboratories
18. Integration of estrogen and progesterone receptors with pathological and molecular prognostic factors in breast cancer patients
19. Prediction of clinical outcome from primary tamoxifen by expression of biologic markers in breast cancer patients
20. Immunohistochemical determination of oestrogen receptor: Comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients
21. Immunohistochemical assessment of oestrogen and progesteron receptors: Correlations with the DCC method and the clinical outcome in primary breast cancer patients
22. A comparative study of hormone receptors in breast cancer with quantitative immunocytochemistry and biochemistry
23. Hormonal receptors in mammary carcinoma: Comparison between quantitative and qualitative methods
24. Estrogen receptor immunohistochemical assay in paraffin embedded tissue. A better Gold Standard?
25. Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer
26. Effect of the formalin tissue fixation and processing on immunohistochemistry
27. Immunohistochemical detection of steroid receptors in breast cancer: A working protocol. UK Receptor Group. UK NEQAS, the Scottish Breast Cancer Pathology Group, and the Receptor and Biomarker Study Group of the EORTC